Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
Watch Live

Health

Researchers are publishing some of the first data in humans that signals psilocybin holds potential for patients with neurodegenerative diseases.
Cannabis-Pic
/
Getty Images
Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.
MORE STORIES